节点文献

艾司西酞普兰治疗抑郁症对照研究

Control study of escitalopram and maprotiline in treatment of depression

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张富毛庆娟施万平张志荣张华彪

【Author】 ZHANG Fu,MAO Qing-juan,SHI Wan-ping,ZHANG Zhi-rong,ZHANG Hua-biao.Shalingzi Hospital of Zhangjiakou City,Zhangjiakou 075131,China

【机构】 河北张家口市沙岭子医院河北张家口市沙岭子医院

【摘要】 目的:探讨艾司西酞普兰治疗抑郁症的疗效及安全性。方法:将63名抑郁症患者随机分为两组,分别给予艾司西酞普兰和马普替林治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表病情严重程度(CGI-SI)、治疗中出现的症状量表(TESS)评定疗效及不良反应。结果:艾司西酞普兰与马普替林治疗抑郁症疗效相当,但艾司西酞普兰起效更快,不良反应更少。结论:艾司西酞普兰治疗抑郁症安全有效。

【Abstract】 Objective:To detect the efficacy and side effects of escitalopram in the treatment of depresssion.Method:63 patients with depression were divided into escitalopram group or maprotiline group respectively for 6 weeks.Hamilton depressive scale(HAMD),clinical global impression severity of illness(CGI-SI)and treatment emergant symptom scale(TESS)were used to evaluate the efficacy and side effects before and after the treatment.Results:There was no significant difference in the efficacy between these two groups.Escitalopram took effect more quickly and less side effects than maprotiline.Conclusion:Escitalopram is a safe and effective antidepressant.

【关键词】 艾司西酞普兰抑郁症
【Key words】 escitalopramdepression
  • 【文献出处】 临床精神医学杂志 ,Journal of Clinical Psychiatry , 编辑部邮箱 ,2008年01期
  • 【分类号】R749.4
  • 【被引频次】28
  • 【下载频次】175
节点文献中: